Click here to get full coverage on Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS) - Seeking Alpha

Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS)  Seeking Alpha

Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS) - Seeking Alpha

Click here to get full coverage on I quit JPMorgan, which didn't fulfill my American dream. Co-founding Hims and launching a startup taught me how to take smart risks. - Business Insider

I quit JPMorgan, which didn't fulfill my American dream. Co-founding Hims and launching a startup taught me how to take smart risks.  Business Insider

I quit JPMorgan, which didn't fulfill my American dream. Co-founding Hims and launching a startup taught me how to take smart risks. - Business Insider

Click here to get full coverage on Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? - The Motley Fool

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?  The Motley Fool

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? - The Motley Fool

Click here to get full coverage on Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser - The New York Times

Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser  The New York Times

Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser - The New York Times

Click here to get full coverage on Why The FDA — And Investors — Just Slammed Hims Stock - Investor's Business Daily

Why The FDA — And Investors — Just Slammed Hims Stock  Investor's Business Daily

Why The FDA — And Investors — Just Slammed Hims Stock - Investor's Business Daily

Click here to get full coverage on Stocks making the biggest moves midday: Webtoon Entertainment, Steel Dynamics, Hims & Hers and more - CNBC

Stocks making the biggest moves midday: Webtoon Entertainment, Steel Dynamics, Hims & Hers and more  CNBC

Stocks making the biggest moves midday: Webtoon Entertainment, Steel Dynamics, Hims & Hers and more - CNBC

Click here to get full coverage on U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims - Reuters

U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims  Reuters

U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims - Reuters

Click here to get full coverage on FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz - AP News

FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz  AP News

FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz - AP News

Click here to get full coverage on Why Hims & Hers Stock Slipped Today - The Motley Fool

Why Hims & Hers Stock Slipped Today  The Motley Fool

Why Hims & Hers Stock Slipped Today - The Motley Fool

Click here to get full coverage on Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 - Hims Investor Relations

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025  Hims Investor Relations

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 - Hims Investor Relations

Click here to get full coverage on Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? - Nasdaq

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?  Nasdaq

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? - Nasdaq

Click here to get full coverage on Taking Advantage Of Hims & Hers Stock Volatility - Investor's Business Daily

Taking Advantage Of Hims & Hers Stock Volatility  Investor's Business Daily

Taking Advantage Of Hims & Hers Stock Volatility - Investor's Business Daily

Click here to get full coverage on Taking Stock of Hims & Hers Health (HIMS) Valuation After Recent Share Price Dip - simplywall.st

Taking Stock of Hims & Hers Health (HIMS) Valuation After Recent Share Price Dip  simplywall.st

Taking Stock of Hims & Hers Health (HIMS) Valuation After Recent Share Price Dip - simplywall.st

Click here to get full coverage on How Hims & Hers founder Joe Spector turned 10 failures into $1B idea - Yahoo Finance

How Hims & Hers founder Joe Spector turned 10 failures into $1B idea  Yahoo Finance

How Hims & Hers founder Joe Spector turned 10 failures into $1B idea - Yahoo Finance

Click here to get full coverage on Why Hims & Hers Health (HIMS) Stock Is Nosediving - TradingView

Why Hims & Hers Health (HIMS) Stock Is Nosediving  TradingView

Why Hims & Hers Health (HIMS) Stock Is Nosediving - TradingView

Click here to get full coverage on Hims and Hers stock price target maintained at $28 by BofA amid weak order trends - Investing.com

Hims and Hers stock price target maintained at $28 by BofA amid weak order trends  Investing.com

Hims and Hers stock price target maintained at $28 by BofA amid weak order trends - Investing.com

Click here to get full coverage on Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office - Business Wire

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office  Business Wire

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office - Business Wire

Click here to get full coverage on Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat

Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS  MarketBeat

Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat

Click here to get full coverage on Hims & Hers Health Faces Revenue Concerns - TipRanks

Hims & Hers Health Faces Revenue Concerns  TipRanks

Hims & Hers Health Faces Revenue Concerns - TipRanks

Click here to get full coverage on Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run - Investor's Business Daily

Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run  Investor's Business Daily

Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run - Investor's Business Daily

Click here to get full coverage on COO Transition and Role Consolidation Might Change the Case For Investing In Hims & Hers Health (HIMS) - simplywall.st

COO Transition and Role Consolidation Might Change the Case For Investing In Hims & Hers Health (HIMS)  simplywall.st

COO Transition and Role Consolidation Might Change the Case For Investing In Hims & Hers Health (HIMS) - simplywall.st

Click here to get full coverage on Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results - Hims Investor Relations

Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results  Hims Investor Relations

Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results - Hims Investor Relations

Click here to get full coverage on Hims & Hers launches treatment plans for low testosterone - Reuters

Hims & Hers launches treatment plans for low testosterone  Reuters

Hims & Hers launches treatment plans for low testosterone - Reuters

Click here to get full coverage on Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)

Hims Hair Loss Solutions: Will the Convenient Option Work for You?  The National Council on Aging (NCOA)

Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)

Click here to get full coverage on US FDA chief says Hims & Hers Super Bowl ad violated drug promotion rules - Reuters

US FDA chief says Hims & Hers Super Bowl ad violated drug promotion rules  Reuters

US FDA chief says Hims & Hers Super Bowl ad violated drug promotion rules - Reuters

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Yahoo Finance

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory  Yahoo Finance

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care - Hims Investor Relations

Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care  Hims Investor Relations

Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care - Hims Investor Relations

Click here to get full coverage on Hims Stock Catapults 126% As Obesity-Drug Wars Rage On Amid FDA Scrutiny - Investor's Business Daily

Hims Stock Catapults 126% As Obesity-Drug Wars Rage On Amid FDA Scrutiny  Investor's Business Daily

Hims Stock Catapults 126% As Obesity-Drug Wars Rage On Amid FDA Scrutiny - Investor's Business Daily

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know  Yahoo Finance

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know  Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Click here to get full coverage on Gold's record high, Rocket Lab equity offering, FDA warns Hims - Yahoo Finance

Gold's record high, Rocket Lab equity offering, FDA warns Hims  Yahoo Finance

Gold's record high, Rocket Lab equity offering, FDA warns Hims - Yahoo Finance

Click here to get full coverage on Hims & Hers Stock Falls After FDA Warns on Super Bowl Campaign - Yahoo Finance

Hims & Hers Stock Falls After FDA Warns on Super Bowl Campaign  Yahoo Finance

Hims & Hers Stock Falls After FDA Warns on Super Bowl Campaign - Yahoo Finance

Click here to get full coverage on Option traders moderately bearish in Hims and Hers Health with shares down 5.36% - TipRanks

Option traders moderately bearish in Hims and Hers Health with shares down 5.36%  TipRanks

Option traders moderately bearish in Hims and Hers Health with shares down 5.36% - TipRanks

Click here to get full coverage on Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025 - Hims Investor Relations

Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025  Hims Investor Relations

Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025 - Hims Investor Relations

Click here to get full coverage on Latham & Watkins Advises on Sale of ZAVA to Hims & Hers Health - Latham & Watkins LLP

Latham & Watkins Advises on Sale of ZAVA to Hims & Hers Health  Latham & Watkins LLP

Latham & Watkins Advises on Sale of ZAVA to Hims & Hers Health - Latham & Watkins LLP

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why  Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Click here to get full coverage on HIMS: BofA Sees Revenue Challenges Ahead - GuruFocus

HIMS: BofA Sees Revenue Challenges Ahead  GuruFocus

HIMS: BofA Sees Revenue Challenges Ahead - GuruFocus

Click here to get full coverage on US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports - Reuters

US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports  Reuters

US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports - Reuters

Click here to get full coverage on Hims & Hers Health Expands Testosterone Offerings - WSJ - The Wall Street Journal

Hims & Hers Health Expands Testosterone Offerings - WSJ  The Wall Street Journal

Hims & Hers Health Expands Testosterone Offerings - WSJ - The Wall Street Journal

Click here to get full coverage on HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - Yahoo Finance

HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?  Yahoo Finance

HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - Yahoo Finance

Click here to get full coverage on Hims & Hers stock falls 12% on revenue miss as company plots expansion into lab testing, longevity - Fierce Healthcare

Hims & Hers stock falls 12% on revenue miss as company plots expansion into lab testing, longevity  Fierce Healthcare

Hims & Hers stock falls 12% on revenue miss as company plots expansion into lab testing, longevity - Fierce Healthcare

Click here to get full coverage on Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 - Hims Investor Relations

Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025  Hims Investor Relations

Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 - Hims Investor Relations

Click here to get full coverage on Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock? - Yahoo Finance

Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?  Yahoo Finance

Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock? - Yahoo Finance

Click here to get full coverage on Hims & Hers Expands Care Ecosystem via Global and Digital Innovation - Yahoo Finance

Hims & Hers Expands Care Ecosystem via Global and Digital Innovation  Yahoo Finance

Hims & Hers Expands Care Ecosystem via Global and Digital Innovation - Yahoo Finance

Click here to get full coverage on Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care - Hims Investor Relations

Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care  Hims Investor Relations

Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care - Hims Investor Relations

Click here to get full coverage on Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer - Hims & Hers Newsroom

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer  Hims & Hers Newsroom

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer - Hims & Hers Newsroom

Click here to get full coverage on Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Hims Investor Relations

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion  Hims Investor Relations

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Hims Investor Relations

Click here to get full coverage on Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem - Yahoo Finance

Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem  Yahoo Finance

Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem - Yahoo Finance

Click here to get full coverage on Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - Yahoo Finance

Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?  Yahoo Finance

Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - Yahoo Finance

Click here to get full coverage on Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug - Pharmaceutical Technology

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug  Pharmaceutical Technology

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug - Pharmaceutical Technology

Click here to get full coverage on Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis - Pharmacy Times

Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis  Pharmacy Times

Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis - Pharmacy Times

Click here to get full coverage on Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - Yahoo Finance

Hims & Hers Drives the Consumer-Centric Transformation in Digital Care  Yahoo Finance

Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - Yahoo Finance

Click here to get full coverage on Hims & Hers Health: Bumpy Ride Will End - Seeking Alpha

Hims & Hers Health: Bumpy Ride Will End  Seeking Alpha

Hims & Hers Health: Bumpy Ride Will End - Seeking Alpha

Click here to get full coverage on UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts? - TipRanks

UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts?  TipRanks

UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts? - TipRanks

Click here to get full coverage on Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership - Reuters

Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership  Reuters

Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership - Reuters

Click here to get full coverage on Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ... - Yahoo Finance

Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ...  Yahoo Finance

Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ... - Yahoo Finance

Click here to get full coverage on HIMS Stock Crashes 30% in a Day: Time to Buy the Dip? - Yahoo Finance

HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?  Yahoo Finance

HIMS Stock Crashes 30% in a Day: Time to Buy the Dip? - Yahoo Finance

Click here to get full coverage on As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? - Reuters

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?  Reuters

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? - Reuters

Click here to get full coverage on Hims to Launch New Offerings for Men With Low Testosterone - Bloomberg.com

Hims to Launch New Offerings for Men With Low Testosterone  Bloomberg.com

Hims to Launch New Offerings for Men With Low Testosterone - Bloomberg.com

Click here to get full coverage on Hims & Hers: Are New Health Products Boosting Stocks? - StocksToTrade

Hims & Hers: Are New Health Products Boosting Stocks?  StocksToTrade

Hims & Hers: Are New Health Products Boosting Stocks? - StocksToTrade

Click here to get full coverage on Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global

Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny  S&P Global

Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global

Click here to get full coverage on Hims & Hers stock falls 10% on revenue miss - CNBC

Hims & Hers stock falls 10% on revenue miss  CNBC

Hims & Hers stock falls 10% on revenue miss - CNBC

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com

Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know  sharewise.com

Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com

Click here to get full coverage on Novo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart  Reuters

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters

Click here to get full coverage on Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS) - Seeking Alpha

Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS)  Seeking Alpha

Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS) - Seeking Alpha

Click here to get full coverage on Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - Hims Investor Relations

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare  Hims Investor Relations

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - Hims Investor Relations

Click here to get full coverage on Novo abruptly ends obesity drug deal with Hims - BioPharma Dive

Novo abruptly ends obesity drug deal with Hims  BioPharma Dive

HIMS

Price Chart

Key Statistics

Technicals

About HIMS

Latest News

Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS) - Seeking Alpha

I quit JPMorgan, which didn't fulfill my American dream. Co-founding Hims and launching a startup taught me how to take smart risks. - Business Insider

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? - The Motley Fool

Advanced Charts

Top Gainers

Top Losers